Pay in installments of $4.28 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
Rosidal haft 6 cmProduct overview Cohesive short stretch bandage Lengthways elastic, approx. 60 % Maintains the compression pressure over an extended time period High working & low resting pressure 1 roll with 5 metres Rosidal haft Rosidal haft is a cohesive short stretch bandage that can be used to treat, for example, phlebological or lymphological conditions. The short stretch bandage maintains the therapeutically necessary compression over an extended period.
Product overview- Cohesive short-stretch bandage
- Lengthways elastic, approx. 60 %
- Maintains the compression pressure over an extended time period
- High working & low resting pressure
- 1 roll with 5 metres
Rosidal haft
Rosidal haft is a cohesive short-stretch bandage that can be used to treat, for example, phlebological or lymphological conditions. The short-stretch bandage maintains the therapeutically necessary compression over an extended period. Rosidal haft has a lengthways elasticity of 60 % and its selvedges ensure a clean finish with no fraying.
The Rosidal haft short-stretch bandage is available as individual rolls in various widths.
Product details
- Rosidal haft
- Cohesive short-stretch bandage
- Approx. 60 % lengthways elasticity
- Elastic fabric thanks to twined warp threads
- Maintains the compression pressure over an extended time period
- High therapeutic and low resting pressure
- With selvedges – prevents the edges from fraying
- Can be used to treat phlebological and lymphological conditions
- Bandage holds reliably
- Material: 99 % polyamide, 1 % synthetic yarns, with microfine natural rubber latex dot coating
- Available in various widths
- 1 roll of 5 metres
Applications of the Rosidal haft short-stretch bandage:
- For phlebological conditions (e.g. varicose veins)
- For lymphological conditions (e.g. oedema)
- For support and relief of the capsular ligament
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.8 ★★★★★
Based on 11 reviews
Sort
Product Reviews
★★★★★ 5
Durable
Size: 6 Big Kid, Color: Aqua/Multi
Good shoes. True to size
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 18, 2026
★★★★★ 5
So good!
Size: 4 Big Kid, Color: Aqua/Multi
As always sketchers give her great support nd comfort while being cute and easy on off! Slip resistant, breathable and size is spot on and super durable wash great and dry quick
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 28, 2025
★★★★★ 5
Fantastic, stylish, and easy shoes!
Size: 2.5 Little Kid, Color: Aqua/Multi
My daughter LOVES these and wears them daily. She says they're really comfy and they slip on easily. They've held up for several months of daily wear so far and are still going strong!
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 15, 2025
★★★★★ 5
Great shoes
Size: 3.5 Big Kid, Color: Hot Pink/Multi
These shoes are awesome! Have good arch support and very comfortable
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 12, 2026
★★★★★ 5
Awesome shoes!
Size: 4 Big Kid, Color: Aqua/Multi
My daughter is SUPER picky about shoes and loves these. They are easy and quick to put on, run true to size, and most important COMFORTABLE. She is outgrowing them and will have to get her the next size up. Highly recommend for picky kids
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 4, 2025